Oncaspar is a cancer medicine used in adults and children to treat acute lymphoblastic leukaemia (ALL), a cancer of white blood cells called lymphoblasts. Oncaspar is used in combination with other cancer medicines. It contains the active substance pegaspargase.
Therapeutic Indication
### Therapeutic indication Oncaspar is indicated as a component of antineoplastic combination therapy in acute lymphoblastic leukaemia (ALL) in paediatric patients from birth to 18 years, and adult patients.
Therapeutic Area (MeSH)
ATC Code
L01XX24
ATC Item
pegaspargase
Pharmacotherapeutic Group
Antineoplastic agents
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| pegaspargase | N/A | 培门冬酶 |
EMA Name
Oncaspar
Medicine Name
Oncaspar
Aliases
N/A